Published in Enferm Infecc Microbiol Clin on February 11, 2009
Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis (2005) 3.02
Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol (2010) 2.05
Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03
Detection of alpha and betacoronaviruses in multiple Iberian bat species. Arch Virol (2011) 1.95
Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain. Enferm Infecc Microbiol Clin (2004) 1.80
Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J Clin Microbiol (2007) 1.59
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1. Clin Infect Dis (2005) 1.52
Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr (2010) 1.44
Correlation between pain, disability, and quality of life in patients with common low back pain. Spine (Phila Pa 1976) (2004) 1.40
[Chlamydophila pneumoniae seroprevalence in adults from the general population]. Med Clin (Barc) (2006) 1.39
Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J Clin Virol (2008) 1.39
Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J (2012) 1.34
Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. PLoS One (2013) 1.30
The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther (2006) 1.28
Human bocavirus detection in nasopharyngeal aspirates of children without clinical symptoms of respiratory infection. Pediatr Infect Dis J (2008) 1.28
Role of rhinovirus C respiratory infections in sick and healthy children in Spain. Pediatr Infect Dis J (2010) 1.21
Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. J Allergy Clin Immunol (2007) 1.08
High incidence of human bocavirus infection in children in Spain. J Clin Virol (2007) 1.08
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill (2016) 1.04
Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain. Pediatr Infect Dis J (2007) 1.04
Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain. Emerg Infect Dis (2003) 1.01
Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain. J Clin Virol (2011) 1.01
Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. J Virol (2009) 1.01
Clinical characteristics of human bocavirus infections compared with other respiratory viruses in Spanish children. Pediatr Infect Dis J (2008) 1.00
Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates. J Virol Methods (2005) 1.00
Implementation of the community network of reference laboratories for human influenza in Europe. J Clin Virol (2005) 0.99
Effectiveness and cost-effectiveness analysis of neuroreflexotherapy for subacute and chronic low back pain in routine general practice: a cluster randomized, controlled trial. Spine (Phila Pa 1976) (2002) 0.97
P4 medicine: the future around the corner. Arch Bronconeumol (2010) 0.94
Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant. Antivir Ther (2010) 0.90
MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus. Cytokine (2012) 0.90
Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain. J Clin Virol (2011) 0.89
Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin (2006) 0.88
Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Gac Sanit (2011) 0.87
Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health (2011) 0.86
Viral acute respiratory infections among infants visited in a rural hospital of southern Mozambique. Trop Med Int Health (2011) 0.86
Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med (2003) 0.85
Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains. J Infect Dev Ctries (2009) 0.85
First report on fatal myocarditis associated with adenovirus infection in Cuba. J Med Virol (2008) 0.85
Influenza C virus infection in children, Spain. Emerg Infect Dis (2006) 0.85
[HIV-2 and HTLV-I/II infections in Spain]. Enferm Infecc Microbiol Clin (2004) 0.84
Enterovirus 75 and aseptic meningitis, Spain, 2005. Emerg Infect Dis (2006) 0.84
Role of rhinovirus C in apparently life-threatening events in infants, Spain. Emerg Infect Dis (2009) 0.84
[Laboratory Network within the Polio Eradication Initiative (1998-2003): six years of surveillance for acute flaccid paralysis in Spain]. Enferm Infecc Microbiol Clin (2006) 0.83
Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain. Emerg Infect Dis (2008) 0.83
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis (2013) 0.83
Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer (2005) 0.83
Haemagglutinin D222G mutation found in a fatal case of pandemic (H1N1) flu in Tunisia. Arch Virol (2012) 0.83
Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother (2015) 0.83
Prospective study of influenza C in hospitalized children. Pediatr Infect Dis J (2013) 0.82
Genetic diversity of HA1 domain of heammaglutinin gene of influenza A(H1N1)pdm09 in Tunisia. Virol J (2013) 0.82
Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season. Euro Surveill (2016) 0.82
Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain. AIDS Res Hum Retroviruses (2009) 0.82
[Avian influenza A (H5N1) infectious in both birds and humans in South-Eastern Asian countries]. Enferm Infecc Microbiol Clin (2004) 0.81
HIV-1 infection in persistently HIV-1-seronegative individuals: more reasons for HIV RNA screening. Clin Infect Dis (2008) 0.81
Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin. J Gen Virol (2014) 0.80
Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection. Pediatr Allergy Immunol (2009) 0.80
Myocarditis caused by human parainfluenza virus in an immunocompetent child initially associated with 2009 influenza A (H1N1) virus. J Clin Microbiol (2011) 0.80
Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain. J Clin Virol (2011) 0.79
Virological Surveillance of Influenza Viruses during the 2008-09, 2009-10 and 2010-11 Seasons in Tunisia. PLoS One (2013) 0.79
Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension? J Clin Virol (2006) 0.79
Increased biomagnetic activity in healthy elderly with subjective memory complaints. Clin Neurophysiol (2010) 0.79
Seroprevalence of antibodies to the influenza A (H1N1) virus among healthcare workers prior to the 2009 pandemic peak. Enferm Infecc Microbiol Clin (2012) 0.79
Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains. PLoS Med (2007) 0.79
Severe acute respiratory syndrome coronavirus accessory proteins 6 and 9b interact in vivo. Virus Res (2012) 0.79